Your browser doesn't support javascript.
loading
Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public-private hospital partnership during the 2022 NYC mpox outbreak.
Mgbako, Ofole; Chan, Justin; Pitts, Robert A; DiLorenzo, Madeline A; Knutsen, Dorothy; Mazo, Dana.
Affiliation
  • Mgbako O; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
  • Chan J; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.
  • Pitts RA; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
  • DiLorenzo MA; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.
  • Knutsen D; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
  • Mazo D; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.
Article in En | MEDLINE | ID: mdl-37502253

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antimicrob Steward Healthc Epidemiol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antimicrob Steward Healthc Epidemiol Year: 2023 Document type: Article Affiliation country: Country of publication: